# Regeneron Pharmaceuticals, Inc.: Form 8-K, filed Oct 7, 2024

- Company: [Regeneron Pharmaceuticals, Inc.](/companies/regn.md) (CIK 872589)
- Form: 8-K
- Filed: 2024-10-07
- Accepted by EDGAR: Oct 7, 2024, 07:00 ET
- Period: 2024-10-07
- Accession: 0001104659-24-106432
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/872589/000110465924106432/tm2419098d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/872589/000110465924106432/

## Items reported

- Item 2.02: Results of operations

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/872589/000110465924106432/tm2419098d1_8k.htm

Filed Oct 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-106432. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.